With new drug development, a significant increase in sales, and high potential with Mounjaro and Zepbound, here’s what we think of Eli Lilly’s stock ...

Minnesota Attorney General Keith Ellison announced on Monday that a settlement has been reached Novo Nordisk over the high ...

Eli Lilly (LLY) announced that the FDA has approved Omvoh for the treatment of moderately to severely active Crohn’s disease in adults. Omvoh is now approved in the U.S. for two types of ...

Eli Lilly (NYSE: LLY) is the most valuable healthcare stock in the world, with a market capitalization of around $720 billion. For a while, it looked like it might be on track to be the first ...

It’s about going home. Former New York Giants quarterback Eli Manning is heading back to the Big Easy for Super Bowl LIX at the Caesars Superdome (happening February 9, 2025) and his return comes with ...

contributed to our Q4 results," Ricks said in a statement. The drugmaker also said it expects sales of $58 billion to $61 billion in fiscal 2025. Eli Lilly is expected to report full quarterly ...

Eli Lilly (LLY) shares traded down more ... all doses of tirzepatide was available throughout Q4," said Lilly CEO David Ricks in a statement. The move in the stock surprised some experts and ...

Eli Lilly and Company (NYSE:LLY) announced on Tuesday that the pharmaceuticals company expects Q4 2024 revenue to be ~$13.5B. The consensus revenue estimate stands at $13.95B. "While the U.S ...

This press release includes forward-looking statements. Statements as such term ... and editorial freedom is essential to our mission of empowering investor success. We provide a platform for ...